论文部分内容阅读
本文观察1985年1月至1986年8月共31例常规治疗无效的急性髓性白血病(AML),用小剂量高三尖杉静脉滴注治疗。患者均经形态学确诊,骨髓或周围血原始细胞大于30%。白血病复发接受高三尖杉治疗
This article observed from January 1985 to August 1986 a total of 31 cases of conventional treatment of acute myeloid leukemia (AML), with a small dose of Cephaloma intravenous infusion treatment. Patients were confirmed by morphology, bone marrow or peripheral blood progenitor cells greater than 30%. Leukemia relapse to accept Cephalotaxis treatment